Biome Eczema contains Lactobacillus salivarius LS-01, a targeted probiotic strain specifically researched for its ability to address eczema and dermatitis through the gut-skin axis. This precision approach recognizes that probiotics work at highly specific biological levels, where individual strains have distinct genetic signatures that determine their therapeutic function in the body.

Lactobacillus salivarius LS01 addresses eczema through sophisticated immune modulation pathways that target the root causes of skin inflammation. This strain works by stabilizing Th1/Th2 immune responses and restoring the decline in interferon-gamma (IFN-γ) typically seen in eczema and dermatitis conditions. Importantly, LS01 significantly reduces fecal Staphylococcus counts, a bacterial genus strongly linked with eczema and dermatitis severity, suggesting beneficial effects on the gut-skin axis and barrier-related inflammation [26].

The clinical evidence for Lactobacillus salivarius LS01 in eczema management is compelling and well-documented. In clinical research involving adults with eczema, treatment with LS01 produced a remarkable 52% reduction in eczema symptoms, compared to a non-significant 17% reduction observed in the placebo group. The probiotic demonstrated excellent tolerability with no reported adverse events throughout the study period [26].

What makes this strain particularly effective is its ability to establish lasting colonization in the digestive system. Research shows that LS01 remained detectable in stool samples in 100% of patients at week 16, demonstrating excellent colonization and persistence during therapy. This sustained presence is crucial for maintaining the immune-modulating benefits that help control eczema flare-ups over time [26].

The targeted nature of this single-strain approach represents a shift from general gut supplements to condition-specific therapeutic tools. By focusing on the precise biological mechanisms needed for eczema management, LS01 offers a more predictable and faster outcome compared to broad-spectrum probiotic blends that may contain irrelevant strains for skin conditions.